Real-world safety profile of spesolimab in generalised pustular psoriasis: expanded access programmes in Japan, China and Argentina.

Spevigo (spesolimab-sbzo) - Boehringer Ingelheim, LEO Pharma

Real-world safety profile of spesolimab in generalised pustular psoriasis: expanded access programmes in Japan, China and Argentina. (PubMed, Br J Dermatol) - Sep 7, 2026 - No abstract available
Journal • Real-world evidence • Dermatology • Immunology • Psoriasis • Pustular Psoriasis

http://www.ncbi.nlm.nih.gov/pubmed/42701320

Aie Xu; Akimichi Morita; Furen Zhang; Keiichi Yamanaka; María Lapadula; María Laura Galimberti; Min Zheng; Nichiren Pillai; Nora Pöntynen; Qianjin Lu; Rafael Sani Simões; Rosana Veira; Xiaoming Liu; Xinghua Gao; Xuemei Ding; Yayoi Tada; Yu-Ling Shi; Yuichiro Tsunemi

Sep 7, 2026